Virtus ETF Advisers LLC Global Blood Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $4,924 - $10,363	152 Added 1.46%	10,558 $719,000
Q2 2022 Aug 12, 2022	SELL	$22.3 - $37.39 $101,063 - $169,451	-4,532 Reduced 30.34%	10,406 $332,000
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $89,142 - $144,130	3,580 Added 31.52%	14,938 $437,000
Q3 2021 Nov 15, 2021	SELL	$25.48 - $37.34 $26,448 - $38,758	-1,038 Reduced 8.37%	11,358 $289,000
Q2 2021 Aug 10, 2021	SELL	$32.46 - $43.42 $73,294 - $98,042	-2,258 Reduced 15.41%	12,396 $434,000
Q1 2021 May 17, 2021	BUY	$38.94 - $50.85 $15,576 - $20,340	400 Added 2.81%	14,654 $597,000
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $185,463 - $314,131	4,926 Added 52.81%	14,254 $617,000
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $41,469 - $58,549	786 Added 9.2%	9,328 $514,000
Q2 2020 Aug 05, 2020	BUY	$48.73 - $81.82 $43,126 - $72,410	885 Added 11.56%	8,542 $539,000
Q1 2020 May 14, 2020	SELL	$41.72 - $87.2 $26,951 - $56,331	-646 Reduced 7.78%	7,657 $391,000
Q4 2019 Feb 13, 2020	BUY	$45.7 - $81.86 $165,708 - $296,824	3,626 Added 77.53%	8,303 $660,000
Q3 2019 Nov 12, 2019	SELL	$45.35 - $57.91 $11,836 - $15,114	-261 Reduced 5.29%	4,677 $227,000
Q2 2019 Aug 13, 2019	SELL	$52.6 - $63.29 $73,850 - $88,859	-1,404 Reduced 22.14%	4,938 $260,000
Q1 2019 May 14, 2019	SELL	$39.99 - $53.48 $30,072 - $40,216	-752 Reduced 10.6%	6,342 $336,000
Q4 2018 Feb 05, 2019	SELL	$31.54 - $46.67 $93,326 - $138,096	-2,959 Reduced 29.43%	7,094 $291,000
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $273,448 - $367,715	-7,196 Reduced 41.72%	10,053 $382,000
Q2 2018 Aug 10, 2018	SELL	$38.7 - $50.15 $80,573 - $104,412	-2,082 Reduced 10.77%	17,249 $780,000
Q1 2018 May 14, 2018	BUY	$39.6 - $65.9 $393,663 - $655,111	9,941 Added 105.87%	19,331 $934,000
Q4 2017 Feb 14, 2018	SELL	$29.7 - $45.7 $72,913 - $112,193	-2,455 Reduced 20.73%	9,390 $370,000
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $27,208 - $33,658	1,084 Added 10.07%	11,845 $368,000
Q2 2017 Aug 14, 2017	BUY	N/A	10,761	10,761 $294,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account